At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
blood transfusionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Viral Activation Transfusion Study (VATS)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Jul 12, 2016
In Brief
A clinical study evaluating blood transfusion for Acquired Immunodeficiency Syndrome and 3 related conditions. Completed.
Detailed Summary
The purpose of the trial was to determine if transfusion of allogeneic blood to HIV-1 infected persons led to immune activation and consequent induction of HIV-1 or /or Cytomegalovirus (CMV) replication, and whether this adversely affected clinical prognosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcquired Immunodeficiency Syndrome, Blood Transfusion, Cytomegalovirus Infections, HIV Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 1994
First PostedOct 1999
Study CompletionMar 2001
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartNov 1, 1994
Study CompletionMar 1, 2001
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
blood transfusionprocedure